5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide

C37H39FN10O4 — CID 164518805

IUPAC5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide
SMILESCNC(=O)c1c(-c2ccc(F)cc2)c(=O)c(C(=O)Nc2ccc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nn2)cn1CC1CCOCC1
InChIInChI=1S/C37H39FN10O4/c1-40-37(51)33-32(23-2-4-26(38)5-3-23)34(49)29(21-47(33)19-22-10-14-52-15-11-22)36(50)44-31-7-6-30(45-46-31)28-16-24(17-42-35(28)39)25-18-43-48(20-25)27-8-12-41-13-9-27/h2-7,16-18,20-22,27,41H,8-15,19H2,1H3,(H2,39,42)(H,40,51)(H,44,46,50)
InChIKeyCSADSDQRVFTDES-UHFFFAOYSA-N
MW706.78 g/mol
LogP3.92
Rot. Bonds9

About 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide

5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide (PubChem CID 164518805) has the molecular formula C37H39FN10O4 and a molecular weight of 706.78 g/mol. Its IUPAC name is 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide.

Molecular Properties

Compound Name5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide
PubChem CID164518805
Molecular FormulaC37H39FN10O4
Molecular Weight706.78 g/mol
Exact Mass706.31
IUPAC Name5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide
SMILESCNC(=O)c1c(-c2ccc(F)cc2)c(=O)c(C(=O)Nc2ccc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nn2)cn1CC1CCOCC1
InChIInChI=1S/C37H39FN10O4/c1-40-37(51)33-32(23-2-4-26(38)5-3-23)34(49)29(21-47(33)19-22-10-14-52-15-11-22)36(50)44-31-7-6-30(45-46-31)28-16-24(17-42-35(28)39)25-18-43-48(20-25)27-8-12-41-13-9-27/h2-7,16-18,20-22,27,41H,8-15,19H2,1H3,(H2,39,42)(H,40,51)(H,44,46,50)
InChIKeyCSADSDQRVFTDES-UHFFFAOYSA-N
XLogP3.92
TPSA183.97 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500706.78
LogP ≤ 53.92
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide?
The IUPAC name of 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide (CID 164518805) is 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide.
What is the SMILES notation for 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide?
The canonical SMILES for 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide is CNC(=O)c1c(-c2ccc(F)cc2)c(=O)c(C(=O)Nc2ccc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)nn2)cn1CC1CCOCC1.
What is the InChIKey of 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide?
The InChIKey is CSADSDQRVFTDES-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H39FN10O4/c1-40-37(51)33-32(23-2-4-26(38)5-3-23)34(49)29(21-47(33)19-22-10-14-52-15-11-22)36(50)44-31-7-6-30(45-46-31)28-16-24(17-42-35(28)39)25-18-43-48(20-25)27-8-12-41-13-9-27/h2-7,16-18,20-22,27,41H,8-15,19H2,1H3,(H2,39,42)(H,40,51)(H,44,46,50).
What are the key properties of 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide?
5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide has a molecular weight of 706.78 g/mol, XLogP of 3.92, 9 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 5-N-[6-[2-amino-5-(1-piperidin-4-ylpyrazol-4-yl)-3-pyridinyl]pyridazin-3-yl]-3-(4-fluorophenyl)-2-N-methyl-1-(oxan-4-ylmethyl)-4-oxopyridine-2,5-dicarboxamide is sourced from PubChem (CID 164518805), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).